History

SCI Pharmtech, Inc. operates a cost effective facility in Taiwan with Swiss quality.

We work with pharmaceutical and specialty companies worldwide to develop key intermediates, APIs and custom products.

Our facility is FDA inspected, designed for multi-purpose, full-scale manufacturing. We care for product quality, safety and environment protection.

We are ISO 9001 and ISO 14001 certified.

Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effective production.

Come to visit our professional employees, and see our 25,000 m2 campus.

Come to check out our quality and price.

Company Overview

Company Name	SCI Pharmtech, Inc
Industry	Pharmaceuticals
Symbol	SCI
Code	4119
Date of Listing	2004/01/07
Chairman	Dr. Yon-Lian Wu
General Manager	Dr. Wei-Chyun Wong
Spokesman	Deiter Yang
Title of Spokesman	Financial & Administration Manager

Fiscal Year_end	DEC 31
Accounting Firm	BDO Taiwan Union & Co
CPA (Chartered Public Accountant)1	Kun Hsi Hsu
CPA (Chartered Public Accountant)2	Kuo Chuan Ko

Address	186-2,Hai-Hu-Tsun,Lu Chu Hsiang
	Taoyuan,Taiwan
Telephone	03-3543133
Fax	03-3543483
Email Address	lisa.kuo@sci-pharmtech.com.tw
Web Address	www.sci-pharmtech.com.tw

Connect to Taiwan Stock Exchange

History about SCI

Month/Year	Events
Sep., 1987	Established by Siegfried (Switzerland) Group as an intermediates provider in Asia. Siegfried owned 80%.
Dec., 1989	Production commenced.
April., 1996	Siegfried Group acquired 100% of shares
Nov., 1999	ISO 14001 certified
April., 2001 Oct., 2001	Mercuries group acquired 80% of shares ISO 9001 certified
April., 2002	Company name changed to "SCI Pharmtech Inc." 35 products commercialized
Jan., 2004 June, 2004 Nov., 2004	Listed on Taiwan stock exchange market Inspected by Taiwan health authorities Rated perfect bonded warehouse by Taiwan customs, and keeps maintaining the status
Dec., 2005	Inspected by FDA

Home About Us Quality System Financial Reports